Prime Medicine, Inc. Common Stock (PRME) Stock Price, Quote & AI Analysis
Live PRME stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for Prime Medicine, Inc. Common Stock.
TradeVae provides AI-driven analysis and real-time market intelligence for Prime Medicine, Inc. Common Stock (PRME), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Prime Medicine, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Prime Medicine, Inc. Common Stock Overview
Company information
Company Overview
Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.
Company Details
Technical Indicators
Key technical analysis metrics and indicators
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Prime Medicine, Inc. Common Stock Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...